Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Capital Hilton

Oct 28, 2024 8:30 AM - Oct 30, 2024 12:40 PM

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Session 2 Track 1: Extra-Hepatic Delivery – Clinical Experience: Emerging

Session Chair(s)

Xing  Jing, PHD, MBA

Xing Jing, PHD, MBA

Reviewer, FDA, United States

Arthur A. Levin, PHD

Arthur A. Levin, PHD

Distinguished Scientist, Avidity Biosciences, United States

Track 1: Extra-Hepatic Delivery – Clinical Experience: Emerging

Speaker(s)

James  Hamilton, MD, MBA

James Hamilton, MD, MBA

Chief of Discovery and Transitional Medicine, Arrowhead Pharmaceuticals, United States

Pulmonary Delivery Platform and Clinical Programs

Thomas  Thum, MD, PHD, FACC

Thomas Thum, MD, PHD, FACC

CSO/CMO, Cardior Pharmaceuticals GmbH, Germany

Cardiac Delivery of Oligonucleotides

Allison  August

Allison August

Chief Medical Officer, Comanche Biopharma, United States

Delivery of siRNA to Placenta for Treatment of Preeclampsia

Steve  Hughes, MD, MBA

Steve Hughes, MD, MBA

Chief Medical Officer, Avidity Biosciences, United States

Delivery of Oligonucleotides to Muscle in Patients

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.